Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Top Cited Papers
- 1 June 2002
- Vol. 324 (7349) , 1287-1288
- https://doi.org/10.1136/bmj.324.7349.1287
Abstract
Acknowledgments We thank Barker Bausell, Jiri Chard, and Matthias Egger for helpful comments, and Wanda Bartolotta for providing data on the number of reprints made available by JAMA.Keywords
This publication has 6 references indexed in Scilit:
- Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.2001
- Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.2001
- Researchers deny any attempt to mislead the public over JAMA article on arthritis drugBMJ, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisProceedings of the National Academy of Sciences, 1999